Pegvisomant-Induced Liver Injury Is Related to the UGT1A1*28 Polymorphism of Gilbert’s Syndrome [PDF]
Ignacio Bernabéu +9 more
openalex +1 more source
Impact of Medical Therapies on Cardiovascular Risk Factors in Acromegaly. [PDF]
Wekesa R +3 more
europepmc +1 more source
Preoperative medical therapy for acromegaly: current knowledge and clinical significance. [PDF]
He D, Wang Q, Sheng Z, Li G.
europepmc +1 more source
PDB89 COST-EFFECTIVENES ANALYSIS OF USING PEGVISOMANT FOR TREATMENT OF ACROMEGALY IN RUSSIA [PDF]
NA Avxentyev +2 more
openalex +1 more source
Interventions to slow aging in humans: Are we ready? [PDF]
et al,, Klein, Samuel
core +1 more source
Regulation of growth-hormone-receptor gene expression by growth hormone and pegvisomant in human mesangial cells [PDF]
Udo Meinhardt +5 more
openalex +1 more source
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes [PDF]
Antonio Bianchi +14 more
openalex +1 more source
Pegvisomant for the Treatment of gsp-Mediated Growth Hormone Excess in Patients with McCune-Albright Syndrome [PDF]
Sunday O. Akintoye +7 more
openalex +1 more source
Growth Hormone Promotes Hepatic Triglyceride Export in Humans.
Baumgartner C +20 more
europepmc +1 more source

